China Medicine Corporation
CHME News Today: Stay Updated with the Latest China Medicine Corporation News in Real Time
Find CHME news now at Meyka AI. Stay informed with the latest China Medicine Corporation stocks updates, including price news, market analysis, and expert insights.

Evercore ISI maintains negative on The Progressive Corporation (PGR) March 2026
PGR analyst rating: Evercore ISI maintained a negative view on PGR on March 18, 2026

SGD/MYR Today April 02: Ringgit Weakens as Oil, War Risks Mount
SGD to MYR edges higher as the ringgit weakens on oil gains and conflict risk. See key drivers, OCBC’s USDMYR outlook, and practical hedging tips for Singapore investors and SMEs.

Barclays Maintains Overweight on Incyte (INCY) Mar 2026
INCY analyst rating: Barclays maintained Overweight on Incyte in Mar 2026, implications for investors and price context

Pre-market mover: 8506.HK S&S Intervalue China up 37.89% to HK$1.31 on 02 Apr 2026, watch volume
Pre-market high-volume: 8506.HK stock jumps to HK$1.31 with 4,140,000 volume; quick metrics, Meyka grade and forecast

Jefferies Maintains Buy on AAR Corp. (AIR) March 24, 2026
Jefferies maintains Buy on AAR Corp. (AIR); latest AIR analyst rating and $150 price target details

BofA Maintains Buy on EL The Estée Lauder Companies Inc. March 2026
BofA maintained Buy on EL. Read the EL analyst rating summary, implications, and Meyka AI grade B

April 01: Toyota CEO Koji Sato Warns Suppliers to Boost Productivity
Koji Sato urges 484 Toyota suppliers to boost productivity and ease cosmetic checks as Chinese EV rivals intensify pressure. With Kenta Kon set to lead, we assess risks and opportunities for German‑ex

Volume spike: PUM.SW stock CHF 21.88 on SIX 01 Apr 2026: 400x volume insight
PUM.SW stock saw a **400x** volume spike to **CHF 21.88** on SIX 01 Apr 2026 with mixed fundamentals and model downside

S$1.20 pre-market RW0U.SI Mapletree North Asia CT (SES) 2 Apr 2026: Volume-led edge
RW0U.SI stock pre-market snapshot at S$1.20 on 02 Apr 2026 with heavy volume and analyst-grade outlook